DRUG INDUSTRY

Amendments

Federal Antitampering Act: enact (S. 216), 11509, 11529 [9MY]

Federal Food, Drug, and Cosmetic Act: amend (S. 2094), 32439 [14NO]

Articles and editorials

Dioxin Charges Are Flawed, 21057 [27JY]

Drug Abuse (sundry), 16239-16241 [16JN]

Emergency Heart Drug's Future Uncertain, 1973 [8FE]

Epinephrine Not Checked By 1938 Food and Drug Act, 1974 [8FE]

Fewer Test Animals Could Mean Safer Drugs, 2095 [10FE]

Firm Recalls Heart Drug; Says Charges—Nonsense, 1769 [3FE]

Hill's Marathon Runner on Health—Montana's Baucus Wields Influence on Pharmacy Issues, 26715 [30SE]

Life-Saving Heart Solution Found Deadly, Doctors Say, 1769 [3FE]

LSD Found To Be Regaining Its Popularity, 21345 [28JY]

Pharmacy Crime Problem Worsens, New Study Finds, 23076 [4AU]

Plough Story, 15992 [15JN]

West Coast Revival of LSD Use Is Predicted To Spread Across Nation, 21345 [28JY]

Winthrop Laboratories Reformulation Eliminates Potential for Misuse of Talwin, 34790 [18NO]

Your Role in Drug Abuse Prevention, 34803 [18NO]

Bills and resolutions

Advertisements and shipments: prohibit mailing illegal (see S. 497)

Counterfeit drugs: prohibit manufacture, distribution, or possession (see S. 503; H.R. 3636)

Labeling: disclose ingredients (see H.R. 4126)

Labeling and advertising: representations concerning approval (see S. 93; H.R. 1554)

Pharmacies: penalties for theft (see H.R. 1032, 2944)

Pharmacists: permit collective negotiation (see H.R. 752)

Regulation (see H.R. 602)

Safety of drugs: assure (see H.R. 837)

Vitamin and mineral products: regulation (see H.R. 839)

Biographies

Johnson, John A., 26408 [29SE]

Letters

Drug labeling requirements, Jeffrey L. Brown, 27933 [7OC]

FDA regulation of Oraflex: Eli Lilly & Co., 32780 [15NO]

Impact of Greek trade practices on U.S. business: Pharmaceutical Manufacturers Association (excerpt), 34879 [18NO]

Pharmacy Protection and Violent Offender Control Act (S. 721): Senator Huddleston, 4290 [8MR]

Urging approval of the Orphan Drug Act, to President Reagan, 190 [6JA]

Remarks in House

Cardiac arrest: heart drug linked to deaths, 1769 [3FE]

Controlled substances: penalties for robbery (H.R. 1255), 1775 [3FE]

Drugs: label disclosure of active ingredients (H.R. 4126), 27933 [7OC]

FDA: regulation of Oraflex, 32780 [15NO]

FDA Approval Labeling Act: introduction (H.R. 1554), 2559 [17FE]

FDA drug approval: provide accurate labeling statement (H.R. 1554), 2559 [17FE]

Flecainide acetate: suspend duty for 2-year period (H.R. 1995), 4869 [10MR]

Food and drugs: impose penalties for tampering (H.R. 778), 898 [26JA]

———impose penalties for tampering (H.R. 1544), 2563 [17FE]

Generic drugs: FDA approval (H.R. 3605), 19844 [19JY]

Heart attack: safety of drug used for emergency treatment, 1972 [8FE]

Orphan drugs: incentives to encourage research and manufacturing, 190 [6JA]

Pharmaceutical products: extend patent term (H.R. 3502), 18383 [30JN], 19104 [13JY]

Pharmacies: penalties for drug thefts (H.R. 3974), 25656 [23SE]

Plough, Abe: tribute, 11126 [4MY], 15992 [15JN]

Public health emergencies: provide for (H.R. 2713), 9559 [21AP]

Winthrop Laboratories: reformulation of drug to prevent street use, 34790 [18NO]

Remarks in Senate

Controlled Substances Robbery Act: enact (S. 422), 20510 [22JY]

Desipramine hydrochloride: suspension of duty (S. 2054), 31038 [4NO]

Dimethylpiperidinium bromide: suspension of duty (S. 2056), 31038 [4NO]

Drug Czar/Drug Commission amendment: proposed (H.R. 3959), 33918 [17NO]

FDA: drug approval status requirements (S. 93), 643 [26JA]

Federal Anti-Tampering Act: enact, 1263 [1FE]

———enact (S. 216), 26610-26613 [30SE]

Federal Antitampering Act: enact (S. 216), 11507 [9MY]

Federal Food, Drug, and Cosmetic Act: amend (S. 2094), 32439 [14NO]

Forane: extend patent, 11715 [10MY]

Imitation Controlled Substances Act: introduction (S. 503), 2323-2324 [16FE]

Johnson, John A.: tribute, 26407 [29SE]

``Look-alike drugs'': increased prevailance, 26100 [28SE]

Marihuana Cultivation on Federal Lands Crime Act: introduction (S. 952), 7200 [24MR]

National Drug Abuse Education Week: designate (S.J. Res. 57), 4463 [9MR]

National Product Safety Week: designate (S. Res. 106), 10970 [4MY]

National War on Violent Crime Act: introduction (S. 315), 1271 [1FE]

Pharmaceutical industry: promoting innovation, 33916 [17NO]

Pharmacy crime: prohibit (S. 109), 749 [26JA]

———worsens, 23076 [4AU]

Pharmacy Protection and Violent Offender Control Act: introduction (S. 721), 4288-4290 [8MR]

Pharmacy robbery (S. 422), 1643 [3FE]

Pharmacy Theft Act: introduction (S. 387), 1400 [2FE]

Rifampin: suspension of duty (S. 2054), 31038 [4NO]

Statements

New Air Drug Interdiction Program at the U.S. Customs Service: Senator DeConcini, 4398 [9MR]

Reimbursement for Prescription Drugs: John A. Johnson for National Association of Retail Druggists, 26401-26404 [29SE]

Your Kids and Drugs—Spot It and Stop It, 28064-28066 [18OC]

Texts of

H.R. 1544, penalties for food, drug, and cosmetic products tampering, 2563 [17FE]

H.R. 2713, provide for public health emergencies, 9560 [21AP]

H.R. 3126, label disclosure of active ingredients in drugs, 27933 [7OC]

S. 93, FDA drug approval status requirements, 643 [26JA]

S. 109, prohibit pharmacy crime, 749 [26JA]

S. 216, Federal Anti-Tampering Act, 26610 [30SE]

S. 216, Federal Antitampering Act, 11510 [9MY]

S. 503, Imitation Controlled Substances Act, 2324 [16FE]

S. 721, Pharmacy Protection and Violent Offender Control Act, 4288 [8MR]

S. 952, Marihuana Cultivation on Federal Lands Crime Act, 7200 [24MR]

S. Res. 106, designate National Product Safety Week, 10970 [4MY]

S.J. Res. 57, designate National Drug Abuse Education Week, 4464 [9MR]